CYP3A4 and major depressive disorder: He et al. demonstrated that ChaihuShugan powder, an anxiety treatment prescription, could increase the protein and mRNA expression of CYP3A4 by activating the progesterone X receptor (PXR) pathway in a mouse model of depression (He et al., 2019).